Thor Advisors’s Boston Scientific BSX Stock Holding History

Thor Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-20,185	Closed	-$821K	–	24
2019 Q3	$821K	Buy	+20,185	New	+$855K	0.94%	26
2019 Q1	$14K	Buy	+375	New	+$14.3K	0.17%	153

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Thor Advisors's BSX Position: Q4 2019 in Review

Thor Advisors sold out of Boston Scientific (BSX) in Q4 2019, closing a stake of 20,185 shares — an estimated $821K sold.

Thor Advisors first reported a position in BSX in Q1 2019 and held it in 2 quarters. The position peaked at $821K in Q3 2019. 853 funds tracked by Wall St. Rank hold BSX as of Q4 2019.

Thor Advisors reported no remaining Boston Scientific position as of Q4 2019 after selling out during the quarter.
Thor Advisors sold 20,185 Boston Scientific shares in Q4 2019, an estimated $821K.
Thor Advisors first reported a position in Boston Scientific in Q1 2019 and held it in 2 quarters.
Thor Advisors's Boston Scientific position peaked at $821K in Q3 2019.
853 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2019.

Based on Thor Advisors's 13F filing for Q4 2019, filed 18 Feb 2020.